Submitted by Anonymous (not verified) on 14 March 2025 - 15:09
Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 02/05/2014, Revision: 25, Status: Authorised
Source: